STACKSTONE WEALTH, LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

STACKSTONE WEALTH, LLC’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07M	Buy	+1,413	New	+$1.07M	0.11%	176

Other funds holding REGN

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return

STACKSTONE WEALTH, LLC's REGN Position: Q3 2026 in Review

STACKSTONE WEALTH, LLC opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1,413 shares worth $1.07M. The stake represents 0.11% of the portfolio and ranks #176 among its holdings.

214 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

STACKSTONE WEALTH, LLC held 1,413 shares of Regeneron Pharmaceuticals worth $1.07M as of Q3 2026.
Regeneron Pharmaceuticals was a new STACKSTONE WEALTH, LLC position in Q3 2026.
Regeneron Pharmaceuticals made up 0.11% of STACKSTONE WEALTH, LLC's portfolio in Q3 2026, its #176 holding.
214 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on STACKSTONE WEALTH, LLC's 13F filing for Q3 2026, filed 19 Oct 2026.